3'-DEAMINO-3'-(4-MORPHOLINYL)DAUNORUBICIN HYDROBROMIDE
UNII 6Q2BUJ5WCZ

Substance Identification & Data

This profile provides standardized clinical and technical data for 3'-deamino-3'-(4-morpholinyl)daunorubicin Hydrobromide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6Q2BUJ5WCZ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 79898-07-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
6Q2BUJ5WCZ
CAS Registry Number
79898-07-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
3'-DEAMINO-3'-(4-MORPHOLINYL)DAUNORUBICIN HYDROBROMIDE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C31H35NO11.BrH
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
VIXOLOLAVBOIIP-SMYDXQIFSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
157398
Unique identification number in the NCBI database of chemical substances.
Substance Type
3?-Deamino-3?-(4-morpholinyl)daunorubicin hydrobromide
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
O1CCN([C@@H]2[C@@H]([C@@H](O[C@](C2)(O[C@H]3C[C@@](Cc4c(c5C(c6c(c(ccc6)OC)C(c5c(O)c43)=O)=O)O)(C(C)=O)O)[H])C)O)CC1.Br

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 3'-deamino-3'-(4-morpholinyl)daunorubicin Hydrobromide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

3′-Deamino-3′-(4-morpholinyl)daunorubicin hydrobromide

Systematic Nomenclature

(7S,9S)-9-Acetyl-6,9,11-trihydroxy-7-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-morpholin-4-yloxan-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrobromide
5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-(4-morpholinyl)-α-L-lyxo-hexopyranosyl]oxy]-, hydrobromide, (8S-cis)-

Technical Codes

NSC-327451

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NLM
PubChem Compound